For overweight or obese patients, that number tops 12,800 per 100,000, and among the broader adult population, more than 5,500 per 100,000 adults are receiving a GLP-1 each quarter as of Q1 2026
Kossoy G, Ben-Hur H, Zusman I, Madar Z, Zuderman Y, Magalovich I, Khavinson V
Competing interests During the conduct of the study, L.A.L
One of the biggest criticisms I've heard of Ozempic and Wegovy the popular diabetes and weight loss medications that have become so popular on TikTok and in Hollywood is about what happens after you're done taking them
Tirzepatide creates the opportunity for weight loss by controlling appetite, but your food choices determine actual results